St. Jude patient Maelin-Kate, age 4, in 2019
Our world-class experts. Your child’s care.
Explore Our Research
Exceptional science. Innovative cures.
Give a gift that could last a lifetime.
Covid-19 updates and information
Race day is Dec. 3! Participate, fundraise, volunteer or cheer.
Read This Patient's Story
Read our new strategic plan and learn about our bold vision for the future.
Read This Article
We have some of the world's best survival rates for some of the most aggressive cancers.
Join our holiday campaign to share the St. Jude mission and make a donation. Every dollar makes a difference.
Visit our St. Jude Gift Shop site
What happens when you give the world’s brightest minds the resources to do something remarkable? Cures.
Hear from some of our famous supporters about why they support St. Jude.
St. Jude recognized for delivering exceptionally high-quality cancer care.
Read This Article
Every dollar you raise makes an impact in the lives of St. Jude children. Learn more about fundraising ideas and how to get started.
Read This Story
We share our research with the world, leading a global effort to understand, treat, and defeat pediatric cancer and other life-threatening diseases.
Make the holidays even more special for the kids of St. Jude by sending them a free virtual holiday card and message.
St. Jude CEO James R. Downing MD is currently leading the $12.9 billion six-year strategic plan, the largest investment in its 60-year history to advance the study and treatment of pediatric cancer and other catastrophic diseases.
Daniel J. Blair, PhD, wins award for early-career scientists working on breakthrough discoveries in health, medicine and science.
The list is based on papers ranked in the top 1% by citations— how often a research paper is referenced by other investigators in their work.
St. Jude scientists studied the role of RNA splicing defects in Alzheimer’s disease, revealing degeneration and toxicity caused by neuron hyperexcitability.
The Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute and
St. Jude announced the largest academic collaboration of its kind.
Cellular response to low oxygen also increases fetal hemoglobin expression in adults, which could lead to novel treatments for some genetic anemias.
More Science & Medicine